W. Schroeder
Papers
3
Total Citations
123
H-Index
3
About
W. Schroeder is a leading clinical researcher in gynecologic oncology, with a focused expertise in borderline ovarian tumours (BOT). Their major contributions stem from the landmark, multicenter AGO ROBOT study, which provided critical, evidence-based insights into this rare ovarian malignancy. Schroeder’s work has been instrumental in defining the prognostic significance of surgical staging, demonstrating that incomplete staging is a negative prognostic factor and clarifying the impact of individual staging procedures on patient outcomes. Their research also revealed age-dependent differences in clinical characteristics and survival, highlighting that younger patients have distinct disease behavior and better prognoses. With key papers accumulating over 120 citations, Schroeder’s findings have directly shaped clinical guidelines for the surgical management and risk stratification of BOT. By leveraging a large, centrally-reviewed cohort, Schroeder’s work has moved the field beyond small retrospective trials, establishing a new standard of care for this patient population and providing clinicians with actionable data to optimize treatment and follow-up strategies.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3